Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-18T05:34:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-11T00:36:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:24:35.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-02-17T15:50:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T10:06:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T08:49:02.000Z thumbnail image

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.